nach oben

Erschienen in:

01.02.2014 | Original Article

The relationship between type 2 diabetes family history, body composition and blood basal glycemia in sedentary people

verfasst von: Antonino Bianco, Francesco Pomara, Margherita Raccuglia, Marianna Bellafiore, Giuseppe Battaglia, Davide Filingeri, Antonio Paoli, Antonio Palma

Erschienen in: Acta Diabetologica | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to verify whether there is a positive correlation between family history to type 2 diabetes mellitus and body mass and composition, and alterations in blood basal glycaemia levels in sedentary male and female. Anthropometric variables, blood parameters, body composition and body surface area were evaluated on 183 male and 237 female sedentary individuals. Participants were classified into two groups: FH⁺ (family history positive) and FH⁻ (familiar history negative) according to their medical history. The FH⁺ group showed higher values of body mass and body surface area than FH⁻ group. These differences were statistically significant (p < 0.05) for the female subgroup. When compared to the FH⁻ group, FH⁺ female individuals showed a significantly greater fat mass (p < 0.01) and a significantly lower free fat mass-to-fat mass ratio (FFM/FM ratio) (p < 0.05). FH⁺ female individuals showed significant lower levels of basal glucose values for Kg of FFM (p < 0.05), FM (p < 0.01) and BSA (p < 0.01) than FH⁻ group. The results of this study indicate that body mass and composition correlate positively to family history to type 2 diabetes. The relationship between family history and body composition is particularly evident in young FH⁺ female. Thus, as family history might represent a risk factor for the development of type 2 diabetes, this could be considered as an important parameter able to predict the onset of the disease itself. This knowledge could be used to improve preventive interventions (i.e. increasing levels of physical activity) promoting healthy lifestyle.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T (2002) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55(1):65–85PubMedCrossRef

Fletcher B, Gulanick M, Lamendola C (2002) Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs 16(2):17–23PubMedCrossRef

Isomaa B, Forsen B, Lahti K, Holmstrom N, Waden J, Matintupa O, Almgren P, Eriksson JG, Lyssenko V, Taskinen MR, Tuomi T, Groop LC (2010) A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 53(8):1709–1713. doi:10.1007/s00125-010-1776-y PubMedCrossRef

Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissén M, Ehrnström BO, Forsén B, Isomaa B, Snickars B, Taskinen MR (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45(11):1585–1593PubMedCrossRef

Erasmus RT, Blanco Blanco E, Okesina AB, Mesa Arana J, Gqweta Z, Matsha T (2001) Importance of family history in type 2 black South African diabetic patients. Postgrad Med J 77(907):323–325PubMedCrossRef

Crispim D, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I (2006) Familial history of type 2 diabetes in patients from Southern Brazil and its influence on the clinical characteristics of this disease. Arq Bras Endocrinol Metabol 50(5):862–868PubMedCrossRef

Rodekamp E, Harder T, Kohlhoff R, Franke K, Dudenhausen JW, Plagemann A (2005) Long-term impact of breast-feeding on body weight and glucose tolerance in children of diabetic mothers: role of the late neonatal period and early infancy. Diabetes Care 28(6):1457–1462PubMedCrossRef

Plagemann A, Harder T, Franke K, Kohlhoff R (2002) Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 25(1):16–22PubMedCrossRef

Bjørnholt JV, Erikssen G, Liestøl K, Jervell J, Thaulow E, Erikssen J (2000) Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 23(9):1255–1259PubMedCrossRef

10.

Bjørnholt JV, Erikssen G, Liestøl K, Jervell J, Erikssen J, Thaulow E (2001) Prediction of Type 2 diabetes in healthy middle-aged men with special emphasis on glucose homeostasis. Results from 22.5 years’ follow-up. Diabet Med 18(4):261–267PubMedCrossRef

11.

Grill V, Persson G, Carlsson S, Norman A, Alvarsson M, Ostensson CG, Svanström L, Efendic S (1999) Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia 42(1):15–23. doi:10.1007/s001250051106 PubMedCrossRef

12.

Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48(1):150–157PubMedCrossRef

13.

Tuomi T (2005) Type 1 and type 2 diabetes: what do they have in common? Diabetes 54(Suppl 2):S40–S45PubMedCrossRef

14.

Hamaguchi K, Kimura A, Kusuda Y, Yamashita T, Yasunami M, Takahasi M, Abe N, Yoshimatsu H (2004) Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes. Diabetes Res Clin Pract 66(2):163–171. doi:10.1016/j.diabres.2004.02.019 PubMedCrossRef

15.

Morales LM, Semprún-Fereira M, Ryder E, Valbuena H, Rincón E, Fernandez V, Flórez H, Campos G, Gómez ME, Raleigh X (1997) Improved triglyceride control with low glycaemic index-high carbohydrate modified-lipid diet in a hypertriglyceridaemic child. Acta Paediatr 86(7):772–774PubMedCrossRef

16.

Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY (2003) Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 26(3):650–655PubMedCrossRef

17.

Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L (2000) Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23(4):465–471PubMedCrossRef

18.

Srinivasan SR, Elkasabani A, Dalferes ER, Bao W, Berenson GS (1998) Characteristics of young offspring of type 2 diabetic parents in a biracial (black-white) community-based sample: the Bogalusa Heart Study. Metabolism 47(8):998–1004PubMedCrossRef

19.

Florez H, Ryder E, Campos G, Fernandez V, Morales LM, Valbuena H, Rincón E, Gómez ME, Raleigh X (1999) Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin 40(2):127–142PubMed

20.

Colucci A, Bianco A, Pomara F, Petrucci M, Grosso F, De Vita A, Adamo V, Palma A (2011) Disease management of type 2 diabetes: a follow-up analysis in a sanitary district of Sicily. Minerva Gastroenterol Dietol 57(3):241–246PubMed

21.

Valdez R (2009) Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol 3(4):722–726PubMedCentralPubMedCrossRef

22.

Gravante G, Pomara F, Angelomè C, Russo G, Truglio G (2001) The basal energy expenditure of female athletes vs. sedentary women as related to their family history of type 2 diabetes. Acta Diabetol 38(2):63–70PubMedCrossRef

23.

Bianco A, Pomara F, Jemni M, Paoli A, Petrucci M, Bellafiore M, Palma A (2011) Influence of family history of NIDDM on basal metabolic rate in sedentary and active women. Panminerva Med 53(4):253–259PubMed

24.

Pomara F, Russo G, Gravante G (2006) Influence of family history to type 2 diabetes on the body composition and homeostasis model assessment: a comparison between young active and sedentary men. Minerva Med 97(5):379–383PubMed

25.

Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA, Brown MD, Miller M, Avery PJ, Alberti KG, Walker M (1997) Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia 40(10):1185–1190. doi:10.1007/s001250050805 PubMedCrossRef

26.

Bozorgmanesh M, Hadaegh F, Azizi F (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids in health disease 9:45. doi:10.1186/1476-511X-9-45 PubMedCrossRef

27.

Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F (2011) Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran lipid and glucose study. Diabet Med 28(11):1330–1336. doi:10.1111/j.1464-5491.2011.03343.x PubMedCrossRef

28.

Gonzalez-Ortiz M, Martinez-Abundis E (1999) Maternal effect of type 2 diabetes mellitus on insulin sensitivity and metabolic profile in healthy young Mexicans. Diabetes Nutr Metab 12(1):32–36PubMed

29.

Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR (2007) Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 56(3):720–727. doi:10.2337/db06-0521 PubMedCrossRef

30.

McClain MR, Srinivasan SR, Chen W, Steinmann WC, Berenson GS (2000) Risk of type 2 diabetes mellitus in young adults from a biracial community: the bogalusa heart study. Prev Med 31(1):1–7. doi:10.1006/pmed.2000.0682 PubMedCrossRef

31.

Al-Lawati JA, Barakat MN, Al-Lawati NA, Al-Maskari MY, Elsayed MK, Mikhailidis DP, Al-Zakwani IS (2013) Cardiovascular risk assessment in diabetes mellitus: comparison of the general framingham risk profile versus the world health organization/international society of hypertension risk prediction charts in arabs–clinical implications. Angiology 64(5):336–342. doi:10.1177/0003319712458349 PubMedCrossRef

32.

Samocha-Bonet D, Campbell LV, Viardot A, Freund J, Tam CS, Greenfield JR, Heilbronn LK (2010) A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia 53(8):1700–1708. doi:10.1007/s00125-010-1768-y PubMedCrossRef

33.

Pomara F, Russo G, Amato G, Gravante G (2005) Familiar history and predictive risk factors to type 2 diabetes: a cross sectional study in young Sicilian subjects of both sexes. Panminerva Med 47(4):259–264PubMed

34.

Weires MB, Tausch B, Haug PJ, Edwards CQ, Wetter T, Cannon-Albright LA (2007) Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes 115(10):634–640. doi:10.1055/s-2007-984443 PubMedCrossRef

35.

Kelly LA, Lane CJ, Weigensberg MJ, Koebnick C, Roberts CK, Davis JN, Toledo-Corral CM, Shaibi GQ, Goran MI (2007) Parental history and risk of type 2 diabetes in overweight Latino adolescents: a longitudinal analysis. Diabetes Care 30(10):2700–2705. doi:10.2337/dc07-0050 PubMedCrossRef

36.

Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, Yang BT, Lang S, Parikh H, Wessman Y, Weishaupt H, Attema J, Abels M, Wierup N, Almgren P, Jansson PA, Ronn T, Hansson O, Eriksson KF, Groop L, Ling C (2012) Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 61:3322–3332 (Epub 2012 Oct 1) doi:10.2337/db11-1653

37.

Pugliese A, Miceli D (2002) The insulin gene in diabetes. Diabetes Metab Res Rev 18(1):13–25PubMedCrossRef

Titel: The relationship between type 2 diabetes family history, body composition and blood basal glycemia in sedentary people
verfasst von: Antonino Bianco
Francesco Pomara
Margherita Raccuglia
Marianna Bellafiore
Giuseppe Battaglia
Davide Filingeri
Antonio Paoli
Antonio Palma
Publikationsdatum: 01.02.2014
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 1/2014
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-013-0502-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

St. John’s wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity

Diabetes mellitus associated with clomipramine treatment: a retrospective analysis

A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance

The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia

Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide